Literature DB >> 2182105

Ultrasonographic measurement of uveal melanoma thickness: interobserver variability.

D H Char1, S Kroll, R D Stone, R Harrie, B Kerman.   

Abstract

We retrospectively reviewed ultrasonographic data on 32 uveal melanomas that had been studied both at a referral institution and at our centre within a six-week period. Generally there were good correlations between ultrasonographic measurements of tumour thickness. The mean absolute difference in ultrasound measurements of tumour thickness was 0.64 mm (range 0-2.2 mm); the mean tumour thickness was 5.2 mm (range 3.5-10.2 mm). Tumour diameter, location, the relative ultrasonographic experience with uveal melanoma, type of equipment, and tumour thickness all affected the interobserver variation of measurement.

Entities:  

Mesh:

Year:  1990        PMID: 2182105      PMCID: PMC1042045          DOI: 10.1136/bjo.74.3.183

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  7 in total

1.  Malignant melanoma of the choroid and ciliary body. A differential diagnosis in clinical echography.

Authors:  K C Ossoinig; F Bigar; S L Kaefring
Journal:  Bibl Ophthalmol       Date:  1975

2.  Effect of various doses of radiation for uveal melanoma on regression, visual acuity, complications, and survival.

Authors:  N A Kindy-Degnan; D H Char; J R Castro; S Kroll; R D Stone; J M Quivey; T L Phillips; A R Irvine
Journal:  Am J Ophthalmol       Date:  1989-02-15       Impact factor: 5.258

3.  Echographic and histologic tumor height measurements in uveal melanoma.

Authors:  D J Coleman
Journal:  Am J Ophthalmol       Date:  1986-01-15       Impact factor: 5.258

4.  Echographic and histologic tumor height measurements in uveal melanoma.

Authors:  D H Nicholson; S Frazier-Byrne; M T Chiu; J Schiffman; J R Hughes; E K Novinski
Journal:  Am J Ophthalmol       Date:  1985-09-15       Impact factor: 5.258

5.  Visual outcome after proton beam irradiation of uveal melanoma.

Authors:  J M Seddon; E S Gragoudas; L Polivogianis; C C Hsieh; K M Egan; M Goitein; L Verhey; J Munzenrider; M Austin-Seymour; M Urie
Journal:  Ophthalmology       Date:  1986-05       Impact factor: 12.079

6.  Choroidal melanoma: comparison of CT, fundoscopy, and US.

Authors:  R G Peyster; J J Augsburger; J A Shields; T V Satchell; A M Markoe; K Clarke; M E Haskin
Journal:  Radiology       Date:  1985-09       Impact factor: 11.105

7.  Diagnostic modalities in choroidal melanoma.

Authors:  D H Char; R D Stone; A R Irvine; J B Crawford; G F Hilton; L I Lonn; A Schwartz
Journal:  Am J Ophthalmol       Date:  1980-02       Impact factor: 5.258

  7 in total
  11 in total

1.  T2 Fluid-Attenuated Inversion Recovery Imaging of Uveal Melanomas and Other Ocular Pathology.

Authors:  Gena M Damento; Kelly K Koeller; Diva R Salomão; Jose S Pulido
Journal:  Ocul Oncol Pathol       Date:  2016-07-01

2.  Gene Expression Profiling in Uveal Melanoma: Five-Year Prospective Outcomes and Meta-Analysis.

Authors:  Thomas M Aaberg; Kyle R Covington; Tony Tsai; Yevgeniy Shildkrot; Kristen M Plasseraud; Katherina M Alsina; Kristen M Oelschlager; Federico A Monzon
Journal:  Ocul Oncol Pathol       Date:  2020-07-06

3.  Interobserver and intraobserver variability of measurements of uveal melanomas using standardised echography.

Authors:  C Haritoglou; A S Neubauer; H Herzum; W R Freeman; A J Mueller
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

4.  Variability of standardized echographic ultrasound using 10 mHz and high-resolution 20 mHz B scan in measuring intraocular melanoma.

Authors:  Daniel Kook; Thomas C Kreutzer; Armin Wolf; Christos Haritoglou
Journal:  Clin Ophthalmol       Date:  2011-04-18

5.  A Comparison of 3 T and 7 T MRI for the Clinical Evaluation of Uveal Melanoma.

Authors:  Michael C Y Tang; Myriam G Jaarsma-Coes; Teresa A Ferreira; Lorna Zwirs-Grech Fonk; Marina Marinkovic; Gregorius P M Luyten; Jan-Willem M Beenakker
Journal:  J Magn Reson Imaging       Date:  2021-10-15       Impact factor: 5.119

6.  Clinical evaluation of ultra-high-field MRI for three-dimensional visualisation of tumour size in uveal melanoma patients, with direct relevance to treatment planning.

Authors:  Jan-Willem M Beenakker; Teresa A Ferreira; Karina P Soemarwoto; Stijn W Genders; Wouter M Teeuwisse; Andrew G Webb; Gregorius P M Luyten
Journal:  MAGMA       Date:  2016-02-25       Impact factor: 2.310

7.  The Economic Value of MR-Imaging for Uveal Melanoma.

Authors:  Lorna Grech Fonk; Teresa A Ferreira; Andrew G Webb; Gregorius P M Luyten; Jan-Willem M Beenakker
Journal:  Clin Ophthalmol       Date:  2020-04-28

8.  Measuring eye deformation between planning and proton beam therapy position using magnetic resonance imaging.

Authors:  Myriam G Jaarsma-Coes; Marina Marinkovic; Eleftheria Astreinidou; Megan S Schuurmans; Femke P Peters; Gregorius P M Luyten; Coen R N Rasch; Jan-Willem M Beenakker
Journal:  Phys Imaging Radiat Oncol       Date:  2020-10-06

9.  Three-dimensional MRI-based treatment planning approach for non-invasive ocular proton therapy.

Authors:  E Fleury; P Trnková; E Erdal; M Hassan; B Stoel; M Jaarma-Coes; G Luyten; J Herault; A Webb; J-W Beenakker; J-P Pignol; M Hoogeman
Journal:  Med Phys       Date:  2021-01-17       Impact factor: 4.071

10.  An Automatic Framework to Create Patient-specific Eye Models From 3D Magnetic Resonance Images for Treatment Selection in Patients With Uveal Melanoma.

Authors:  Mohamed Kilany Hassan; Emmanuelle Fleury; Denis Shamonin; Lorna Grech Fonk; Marina Marinkovic; Myriam G Jaarsma-Coes; Gregorius P M Luyten; Andrew Webb; Jan-Willem Beenakker; Berend Stoel
Journal:  Adv Radiat Oncol       Date:  2021-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.